loadpatents
name:-0.027471780776978
name:-0.014579057693481
name:-0.0091261863708496
AXTEN; Jeffrey Michael Patent Filings

AXTEN; Jeffrey Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for AXTEN; Jeffrey Michael.The latest application filed is for "chemical compounds as atf-4 pathway inhibitors".

Company Profile
6.16.22
  • AXTEN; Jeffrey Michael - Collegeville PA
  • AXTEN; Jeffrey Michael - Stevenage GB
  • Axten; Jeffrey Michael - King of Prussia PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Chemical Compounds as ATF-4 Pathway Inhibitors
App 20210093619 - AXTEN; Jeffrey Michael ;   et al.
2021-04-01
Chemical compounds
Grant 10,851,053 - Axten , et al. December 1, 2
2020-12-01
Chemical Compounds
App 20200297710 - AXTEN; Jeffrey Michael ;   et al.
2020-09-24
Chemical Compounds
App 20190298705 - AXTEN; Jeffrey Michael ;   et al.
2019-10-03
Isoquinoline Derivatives As Perk Inhibitors
App 20190241573 - AXTEN; Jeffrey Michael ;   et al.
2019-08-08
Chemical Compounds
App 20190144384 - AXTEN; Jeffrey Michael ;   et al.
2019-05-16
Chemical Compounds
App 20180237441 - AXTEN; Jeffrey Michael ;   et al.
2018-08-23
Chemical compounds
Grant 8,697,685 - Axten , et al. April 15, 2
2014-04-15
Chemical compounds
Grant 8,598,156 - Axten , et al. December 3, 2
2013-12-03
Chemical compounds
Grant 8,383,635 - Atkinson , et al. February 26, 2
2013-02-26
Chemical Compounds
App 20130018038 - Axten; Jeffrey Michael ;   et al.
2013-01-17
Chemical Compounds
App 20120077828 - Axten; Jeffrey Michael ;   et al.
2012-03-29
Chemical Compounds
App 20110275611 - Axten; Jeffrey Michael ;   et al.
2011-11-10
Peptide deformylase inhibitors
Grant 7,982,053 - Axten , et al. July 19, 2
2011-07-19
Chemical Compounds
App 20110136838 - Atkinson; Francis Louis ;   et al.
2011-06-09
Anthranilamide inhibitors of aurora kinase
Grant 7,884,098 - Axten , et al. February 8, 2
2011-02-08
Antimicrobial Compounds
App 20100081650 - Axten; Jeffrey Michael ;   et al.
2010-04-01
Anthranilamide Inhibitors Of Aurora Kinase
App 20100016318 - Axten; Jeffrey Michael ;   et al.
2010-01-21
Antibacterial agents
Grant 7,648,984 - Miller , et al. January 19, 2
2010-01-19
Antibacterial compounds
Grant 7,622,481 - Axten , et al. November 24, 2
2009-11-24
Antibacterial agents
Grant 7,618,959 - Axten , et al. November 17, 2
2009-11-17
Peptide Deformylase Inhibitors
App 20090239866 - Axten; Jeffrey Michael ;   et al.
2009-09-24
Compounds
Grant 7,498,326 - Axten , et al. March 3, 2
2009-03-03
Azaindole inhibitors of aurora kinases
Grant 7,495,102 - Sarpong , et al. February 24, 2
2009-02-24
Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
Grant 7,491,714 - Axten , et al. February 17, 2
2009-02-17
Azaindole Inhibitors Of Aurora Kinases
App 20080081808 - Sarpong; Martha A. ;   et al.
2008-04-03
Antibacterial Agents
App 20070203127 - Miller; William Henry ;   et al.
2007-08-30
Antibacterial agents
Grant 7,232,832 - Axten , et al. June 19, 2
2007-06-19
Antibacterial agents
App 20070004710 - Axten; Jeffrey Michael ;   et al.
2007-01-04
Compounds
App 20060189604 - Axten; Jeffrey Michael ;   et al.
2006-08-24
Antibacterial agents
App 20060166977 - Axten; Jeffrey Michael ;   et al.
2006-07-27
Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
App 20060116512 - Axten; Jeffrey Michael ;   et al.
2006-06-01
Compounds
App 20060058287 - Axten; Jeffrey Michael ;   et al.
2006-03-16
Antibacterial agents
App 20060041123 - Axten; Jeffrey MICHAEL ;   et al.
2006-02-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed